Crossref
Photobiomodulation versus Meloxicam in myofascial pain disorder syndrome: a double-blind clinical trial study
Lasers in Dental Science · 22.05.2026 · 10 (1)
DOI: 10.1007/s41547-026-00333-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lasers in Dental Science, online erschienen am 22.05.2026. Verfasst von Hamed Haji Mokhtari und 2 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mokhtari, H. H., Miramirkhany, S., & Noormohammadi, R. (2026). Photobiomodulation versus Meloxicam in myofascial pain disorder syndrome: a double-blind clinical trial study. Lasers in Dental Science, 10(1). https://doi.org/10.1007/s41547-026-00333-4
Vancouver
Mokhtari HH, Miramirkhany S, Noormohammadi R. Photobiomodulation versus Meloxicam in myofascial pain disorder syndrome: a double-blind clinical trial study. Lasers in Dental Science. 2026;10(1). doi:10.1007/s41547-026-00333-4
BibTeX
@article{Mokhtari2026,
author = {Mokhtari, Hamed Haji and Miramirkhany, Sepehr and Noormohammadi, Robab},
title = {Photobiomodulation versus Meloxicam in myofascial pain disorder syndrome: a double-blind clinical trial study},
journal = {Lasers in Dental Science},
year = {2026},
volume = {10},
number = {1},
doi = {10.1007/s41547-026-00333-4}
}
EUVIMED